QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
NYSE:BAX

Baxter International (BAX) Competitors

$40.72
+0.39 (+0.97%)
(As of 05/31/2023 ET)
Compare
Today's Range
$39.92
$40.95
50-Day Range
$38.12
$47.68
52-Week Range
$37.35
$76.51
Volume
12.53 million shs
Average Volume
6.28 million shs
Market Capitalization
$20.60 billion
P/E Ratio
N/A
Dividend Yield
2.85%
Price Target
$52.38

BAX vs. PODD, TFX, RMD, GMED, DXCM, BDX, BSX, WST, PEN, and SWAV

Should you be buying Baxter International stock or one of its competitors? The main competitors of Baxter International include Insulet (PODD), Teleflex (TFX), ResMed (RMD), Globus Medical (GMED), DexCom (DXCM), Becton, Dickinson and (BDX), Boston Scientific (BSX), West Pharmaceutical Services (WST), Penumbra (PEN), and Shockwave Medical (SWAV). These companies are all part of the "surgical & medical instruments" industry.

Baxter International vs.

Baxter International (NYSE:BAX) and Insulet (NASDAQ:PODD) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

84.8% of Baxter International shares are held by institutional investors. 0.3% of Baxter International shares are held by insiders. Comparatively, 0.8% of Insulet shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Insulet has lower revenue, but higher earnings than Baxter International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baxter International$15.11 billion1.36-$2.43 billion-$4.88-8.34
Insulet$1.37 billion13.97$4.60 millionN/AN/A

In the previous week, Insulet had 3 more articles in the media than Baxter International. MarketBeat recorded 12 mentions for Insulet and 9 mentions for Baxter International. Insulet's average media sentiment score of 0.78 beat Baxter International's score of 0.36 indicating that Insulet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Baxter International
0 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Insulet
4 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Baxter International has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500. Comparatively, Insulet has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500.

Baxter International received 28 more outperform votes than Insulet when rated by MarketBeat users. Likewise, 67.16% of users gave Baxter International an outperform vote while only 66.48% of users gave Insulet an outperform vote.

CompanyUnderperformOutperform
Baxter InternationalOutperform Votes
722
67.16%
Underperform Votes
353
32.84%
InsuletOutperform Votes
694
66.48%
Underperform Votes
350
33.52%

Insulet has a net margin of 0.04% compared to Baxter International's net margin of -16.34%. Baxter International's return on equity of 24.29% beat Insulet's return on equity.

Company Net Margins Return on Equity Return on Assets
Baxter International -16.34% 24.29% 5.49%
Insulet 0.04% 17.29% 3.59%

Baxter International currently has a consensus target price of $52.38, indicating a potential upside of 28.62%. Insulet has a consensus target price of $330.00, indicating a potential upside of 20.33%. Given Baxter International's higher possible upside, analysts clearly believe Baxter International is more favorable than Insulet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baxter International
1 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.21
Insulet
0 Sell rating(s)
7 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.46

Summary

Insulet beats Baxter International on 10 of the 17 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAX vs. The Competition

MetricBaxter InternationalSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$20.60B$3.50B$4.48B$14.25B
Dividend Yield2.81%2.93%2.32%4.06%
P/E Ratio-8.3428.9494.8518.54
Price / Sales1.3654.673,615.039.06
Price / Cash3.2964.2694.4923.16
Price / Book3.475.265.009.09
Net Income-$2.43B$59.42M$117.38M$896.31M
7 Day Performance-3.32%-1.74%-1.70%-1.03%
1 Month Performance-14.60%-2.00%0.74%-2.92%
1 Year Performance-46.46%-11.23%18.41%-10.42%

Baxter International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PODD
Insulet
2.2839 of 5 stars
$272.58
0.0%
$330.00
+21.1%
+15.9%$19.00B$1.31B233.022,600Analyst Revision
TFX
Teleflex
2.5131 of 5 stars
$232.06
-0.1%
$271.75
+17.1%
-20.0%$10.88B$2.79B30.2615,500Analyst Report
RMD
ResMed
2.5964 of 5 stars
$209.98
-2.5%
$263.43
+25.5%
+0.8%$30.85B$3.58B35.778,160
GMED
Globus Medical
2.5485 of 5 stars
$52.61
-0.6%
$70.50
+34.0%
-21.3%$5.28B$759.12M26.712,600Short Interest ↑
DXCM
DexCom
1.9941 of 5 stars
$113.56
-1.3%
$126.81
+11.7%
+57.1%$44.02B$2.91B162.237,600High Trading Volume
BDX
Becton, Dickinson and
2.8477 of 5 stars
$238.31
-1.2%
$276.60
+16.1%
-7.1%$67.68B$18.87B44.7177,000
BSX
Boston Scientific
2.6239 of 5 stars
$50.49
-1.1%
$53.89
+6.7%
+22.5%$70.69B$12.68B85.5845,000Analyst Report
Short Interest ↓
WST
West Pharmaceutical Services
2.5967 of 5 stars
$336.32
-2.1%
$313.00
-6.9%
+4.7%$24.97B$2.89B46.2013,550Insider Selling
PEN
Penumbra
2.0128 of 5 stars
$310.72
+1.4%
$296.33
-4.6%
+108.0%$11.89B$847.13M1,942.123,900
SWAV
Shockwave Medical
2.4154 of 5 stars
$276.14
-1.6%
$273.78
-0.9%
+58.4%$10.27B$557.17M43.561,001Analyst Report
Insider Selling

Related Companies and Tools

This page (NYSE:BAX) was last updated on 5/31/2023 by MarketBeat.com Staff

My Account -